Asia-Pacific Osteoporosis Drugs Market Expected to Witness the Fastest Growth (4.2% CAGR) Globally, During 2016 – 2022
The global osteoporosis drugs market is growing at a significant rate due to growing geriatric population, increasing awareness of osteoporosis and increasing healthcare expenditure. The increasing prevalence of osteoporosis in postmenopausal women and the increasing focus on research & development of new drugs for treatment of osteoporosis are also driving the growth of the global osteoporosis drugs market.
View full press release